XML 59 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Cash and Cash Equivalents - Narrative (Details)
Jun. 30, 2020
USD ($)
patient
Dec. 31, 2019
USD ($)
Cash and Cash Equivalents [Line Items]    
Cash and cash equivalents $ 245,735,000 $ 125,699,000
Cash 3,400,000 3,200,000
Investments in money market funds, U.S. Treasury securities and certain short-term investment-grade corporate debt securities with original maturities of 90 days or less 242,400,000 122,500,000
Available for sale securities $ 0 $ 0
GATHER2 Trial    
Cash and Cash Equivalents [Line Items]    
Number of patients planned to enroll in trial | patient 400